Novo Nordisk A/S purchases B shares worth DKK 2,913 million from Novo Holdings A/S under the 2020 share repurchase programme
November 03 2020 - 2:49PM
Novo Nordisk A/S purchases B shares worth DKK 2,913 million from
Novo Holdings A/S under the 2020 share repurchase programme
Novo Nordisk A/S purchases B shares worth DKK 2,913
million from Novo Holdings A/S under the 2020 share repurchase
programme
Bagsværd, Denmark, 3 November 2020 — Novo
Nordisk A/S has today entered into an agreement to purchase
7,012,500 B shares of DKK 0.20 to a value of DKK 2,913 million from
Novo Holdings A/S. This transaction is part of Novo Nordisk A/S’
2020 share repurchase programme of up to a total of DKK 17 billion
to be executed during a 12-month period beginning 5 February 2020.
The transaction price is DKK 415.35 per share and has been
calculated as the three-day volume weighted average market price
from 30 October 2020 to 3 November 2020 in the open window
following the announcement of Novo Nordisk A/S’ quarterly financial
results.
Prior to the sale of B shares, Novo Holdings A/S’ ownership of
Novo Nordisk A/S was 28.3% of the share capital and 76.6% of the
votes. Following the transaction, Novo Holdings A/S owns
537,436,000 A shares of DKK 0.20 and 121,739,000 B shares of DKK
0.20, corresponding to 28.1% of the capital and 76.5% of the votes
in Novo Nordisk A/S.
The transaction is in line with the announcement on 30 October
2020 that Novo Holdings A/S intends to maintain its ownership of
Novo Nordisk A/S’ share capital around 28%.
In addition, transactions related to Novo Nordisk’s incentive
programmes have resulted in a net transfer from Novo Nordisk of
37,377 B shares in the period from 30 October 2020 to 3 November
2020.
With the transactions stated above, Novo Nordisk A/S owns a
total of 33,536,869 B shares of DKK 0.20, corresponding to 1.4% of
the share capital, as treasury shares. The total amount of A and B
shares in the company is 2,350,000,000 of DKK 0.20 including
treasury shares.
About Novo Holdings A/S
Novo Holdings A/S is a private limited liability company wholly
owned by the Novo Nordisk Foundation. It is the holding company of
the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and
is responsible for managing the Novo Nordisk Foundation’s assets.
Novo Holdings is recognized as a leading international life science
investor, with a focus on creating long-term value. As a life
science investor, Novo Holdings provides seed and venture capital
to development-stage companies and takes significant ownership
positions in growth and well-established companies. Novo Holdings
also manages a broad portfolio of diversified financial assets.
Further information: www.novoholdings.dk.
About Novo Nordisk A/S Novo Nordisk is a
leading global healthcare company, founded in 1923 and
headquartered in Denmark. Our purpose is to drive change to defeat
diabetes and other serious chronic diseases such as obesity and
rare blood and endocrine disorders. We do so by pioneering
scientific breakthroughs, expanding access to our medicines and
working to prevent and ultimately cure disease. Novo Nordisk
employs about 44,000 people in 80 countries and markets its
products in around 170 countries. Novo Nordisk's B shares are
listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the
New York Stock Exchange (NVO). For more information, visit
novonordisk.com, Facebook, Twitter, LinkedIn, YouTube.
Further information
Media: |
|
|
Mette Kruse
Danielsen |
+45 4442
3883 |
mkd@novonordisk.com |
Ken Inchausti
(US) |
+1 609 240
9429 |
kiau@novonordisk.com |
|
|
|
Investors: |
|
|
Daniel Muusmann
Bohsen |
+45 3075
2175 |
dabo@novonordisk.com |
Valdemar Borum
Svarrer |
+45 3079
0301 |
jvls@novonordisk.com |
Ann Søndermølle
Rendbæk |
+45 3075
2253 |
arnd@novonordisk.com |
Mark Joseph
Root |
+45 3079
4211 |
mjhr@novonordisk.com |
Kristoffer Due
Berg US) |
+1 609 235
2989 |
krdb@novonordisk.com |
Company announcement No. 64 / 2020
- PR20201103 - NHAS buyback
Novo Nordisk (TG:NOVC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Novo Nordisk (TG:NOVC)
Historical Stock Chart
From Jul 2023 to Jul 2024